Skip to main content
. 2022 Dec;11(12):1908–1923. doi: 10.21037/gs-22-701

Figure 5.

Figure 5

Survival curve for the BRAFV600E mutation & PD-L1 and the recurrence of early-stage PTC (log rank P=0.324) (A); survival curve for the BRAFV600E mutation & PD-L1 and PTMC recurrence (log rank P=0.076) (B). PD-L1, programmed death-ligand 1; PTMC, papillary thyroid microcarcinoma.